相似文献
1
Interaction of a fragment of the cannabinoid CB1 receptor C-terminus with arrestin-2.
FEBS Lett. 2007 Oct 16;581(25):5009-16. doi: 10.1016/j.febslet.2007.09.030. Epub 2007 Sep 24.
2
Binding between a distal C-terminus fragment of cannabinoid receptor 1 and arrestin-2.
Biochemistry. 2011 Mar 29;50(12):2223-34. doi: 10.1021/bi1018144. Epub 2011 Feb 28.
3
1H NMR structural and functional characterisation of a cAMP-specific phosphodiesterase-4D5 (PDE4D5) N-terminal region peptide that disrupts PDE4D5 interaction with the signalling scaffold proteins, beta-arrestin and RACK1.
Cell Signal. 2007 Dec;19(12):2612-24. doi: 10.1016/j.cellsig.2007.08.015. Epub 2007 Sep 1.
4
Activation-dependent conformational changes in {beta}-arrestin 2.
J Biol Chem. 2004 Dec 31;279(53):55744-53. doi: 10.1074/jbc.M409785200. Epub 2004 Oct 22.
5
Structural Insights into β-arrestin/CB1 Receptor Interaction: NMR and CD Studies on Model Peptides.
Int J Mol Sci. 2020 Oct 30;21(21):8111. doi: 10.3390/ijms21218111.
6
Conformational changes in the phosphorylated C-terminal domain of rhodopsin during rhodopsin arrestin interactions.
J Biol Chem. 2004 Dec 3;279(49):51203-7. doi: 10.1074/jbc.M407341200. Epub 2004 Sep 6.
7
Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites.
Mol Pharmacol. 2017 Feb;91(2):75-86. doi: 10.1124/mol.116.104638. Epub 2016 Nov 28.
8
Beta-arrestin-based Bret2 screening assay for the "non"-beta-arrestin binding CB1 receptor.
J Biomol Screen. 2009 Apr;14(4):371-80. doi: 10.1177/1087057109333101.
9
Distinct roles of β-arrestin 1 and β-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1).
J Biol Chem. 2013 Apr 5;288(14):9790-9800. doi: 10.1074/jbc.M112.438804. Epub 2013 Feb 28.
10
Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide.
Nature. 2013 May 2;497(7447):137-41. doi: 10.1038/nature12120. Epub 2013 Apr 21.
引用本文的文献
1
SGIP1 in axons prevents internalization of desensitized CB1R and modifies its function.
Front Neurosci. 2023 Jul 20;17:1213094. doi: 10.3389/fnins.2023.1213094. eCollection 2023.
2
Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB receptor density in cell membranes: an alternative to radioligand binding methods.
Microb Cell Fact. 2022 Sep 15;21(1):192. doi: 10.1186/s12934-022-01914-1.
3
SGIP1 modulates kinetics and interactions of the cannabinoid receptor 1 and G protein-coupled receptor kinase 3 signalosome.
J Neurochem. 2022 Mar;160(6):625-642. doi: 10.1111/jnc.15569. Epub 2022 Jan 11.
4
Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease.
Biomolecules. 2020 Nov 27;10(12):1609. doi: 10.3390/biom10121609.
5
Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases.
Int J Mol Sci. 2020 Oct 17;21(20):7693. doi: 10.3390/ijms21207693.
6
Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R).
Front Mol Neurosci. 2020 Jun 12;13:108. doi: 10.3389/fnmol.2020.00108. eCollection 2020.
7
Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds.
ACS Pharmacol Transl Sci. 2019 Nov 4;3(2):285-295. doi: 10.1021/acsptsci.9b00069. eCollection 2020 Apr 10.
8
Molecular Interaction between Distal C-Terminal Domain of the CB Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b).
J Chem Inf Model. 2019 Dec 23;59(12):5294-5303. doi: 10.1021/acs.jcim.9b00948. Epub 2019 Dec 10.
9
Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure.
Molecules. 2019 Oct 12;24(20):3672. doi: 10.3390/molecules24203672.
10
Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence.
Front Pharmacol. 2019 Apr 10;10:350. doi: 10.3389/fphar.2019.00350. eCollection 2019.
本文引用的文献
1
Physiological roles of G protein-coupled receptor kinases and arrestins.
Annu Rev Physiol. 2007;69:511-34. doi: 10.1146/annurev.physiol.69.022405.154731.
2
G-protein coupled receptor structure.
Biochim Biophys Acta. 2007 Apr;1768(4):808-24. doi: 10.1016/j.bbamem.2006.10.002. Epub 2006 Oct 10.
3
Cannabinoid receptors as therapeutic targets.
Curr Pharm Des. 2006;12(14):1751-69. doi: 10.2174/138161206776873743.
4
Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin.
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4900-5. doi: 10.1073/pnas.0600733103. Epub 2006 Mar 17.
5
The three-dimensional structure of alpha1-purothionin in solution: combined use of nuclear magnetic resonance, distance geometry and restrained molecular dynamics.
EMBO J. 1986 Oct;5(10):2729-35. doi: 10.1002/j.1460-2075.1986.tb04557.x.
6
GPCR-induced dissociation of G-protein subunits in early stage signal transduction.
Mol Membr Biol. 2005 Nov-Dec;22(6):507-17. doi: 10.1080/09687860500370604.
7
The conformation of a signal peptide bound by Escherichia coli preprotein translocase SecA.
J Biol Chem. 2005 Sep 23;280(38):32753-60. doi: 10.1074/jbc.M507532200. Epub 2005 Jul 26.
8
The conformation of the cytoplasmic helix 8 of the CB1 cannabinoid receptor using NMR and circular dichroism.
Biochim Biophys Acta. 2005 Feb 1;1668(1):1-9. doi: 10.1016/j.bbamem.2004.10.011.
9
Conformational changes in the phosphorylated C-terminal domain of rhodopsin during rhodopsin arrestin interactions.
J Biol Chem. 2004 Dec 3;279(49):51203-7. doi: 10.1074/jbc.M407341200. Epub 2004 Sep 6.
10
Desensitization of G protein-coupled receptors and neuronal functions.
Annu Rev Neurosci. 2004;27:107-44. doi: 10.1146/annurev.neuro.27.070203.144206.
Zotero 插件